CVE-2025-4599: CWE-79 Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') in Liferay Portal
The fragment preview functionality in Liferay Portal 7.4.3.61 through 7.4.3.132, and Liferay DXP 2024.Q4.1 through 2024.Q4.5, 2024.Q3.1 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.13 and 7.4 update 61 through update 92 was found to be vulnerable to postMessage-based XSS because it allows a remote non-authenticated attacker to inject JavaScript into the fragment portlet URL.
AI Analysis
Technical Summary
CVE-2025-4599 is a Cross-Site Scripting (XSS) vulnerability identified in the fragment preview functionality of Liferay Portal versions 7.4.3.61 through 7.4.3.132 and multiple versions of Liferay DXP 2024 quarterly releases. The vulnerability arises due to improper neutralization of input during web page generation, specifically involving the postMessage API. This flaw allows a remote attacker, without requiring authentication, to inject malicious JavaScript code into the fragment portlet URL. When a victim accesses the affected fragment preview, the injected script executes in the context of the user's browser, potentially leading to session hijacking, credential theft, or unauthorized actions on behalf of the user. The vulnerability is classified under CWE-79, which pertains to improper input sanitization leading to XSS. Despite the vulnerability's presence in multiple versions, the CVSS v4.0 score is low (2.0), indicating limited impact or exploitation complexity. The vector details suggest network attack vector (AV:N), low attack complexity (AC:L), but require privileges and user interaction (PR:H/UI:P), with low impact on confidentiality and integrity and no impact on availability. No known exploits are currently reported in the wild, and no patches have been linked yet. The vulnerability affects the fragment preview feature, which is used to render and preview UI components, making it a targeted attack vector for injecting malicious scripts via crafted URLs.
Potential Impact
For European organizations using Liferay Portal or Liferay DXP, this vulnerability poses a risk primarily to web application security and user trust. Exploitation could lead to theft of session cookies, enabling attackers to impersonate legitimate users, potentially accessing sensitive data or performing unauthorized actions within the portal. This is particularly concerning for organizations that use Liferay for intranet portals, customer-facing websites, or digital experience platforms that handle personal data or business-critical information. Although the CVSS score is low, the fact that the vulnerability can be exploited remotely without authentication increases the attack surface. European organizations subject to GDPR must consider the risk of data breaches resulting from such attacks, which could lead to regulatory penalties and reputational damage. The impact is somewhat mitigated by the requirement for user interaction and privileges, but phishing or social engineering could facilitate exploitation. Additionally, the fragment preview functionality is often used by developers and content managers, so targeted attacks against these roles could disrupt business operations or lead to privilege escalation within the portal environment.
Mitigation Recommendations
European organizations should implement the following specific mitigations: 1) Immediately audit and restrict access to the fragment preview functionality to trusted users only, minimizing exposure to untrusted or anonymous users. 2) Apply strict Content Security Policy (CSP) headers to limit the execution of unauthorized scripts within the portal context. 3) Monitor and filter incoming URLs to the fragment portlet for suspicious or malformed parameters that could carry injected scripts. 4) Educate users, especially content managers and developers, about the risks of clicking on untrusted links related to the portal. 5) Regularly update Liferay Portal and DXP to the latest versions once patches addressing CVE-2025-4599 are released. 6) Employ web application firewalls (WAFs) with custom rules to detect and block exploitation attempts targeting the fragment preview URLs. 7) Conduct internal penetration testing focusing on the fragment preview feature to identify any additional weaknesses. These measures go beyond generic advice by focusing on access control, input validation, user awareness, and proactive monitoring tailored to this specific vulnerability.
Affected Countries
Germany, United Kingdom, France, Netherlands, Sweden, Belgium, Italy
CVE-2025-4599: CWE-79 Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') in Liferay Portal
Description
The fragment preview functionality in Liferay Portal 7.4.3.61 through 7.4.3.132, and Liferay DXP 2024.Q4.1 through 2024.Q4.5, 2024.Q3.1 through 2024.Q3.13, 2024.Q2.0 through 2024.Q2.13, 2024.Q1.1 through 2024.Q1.13 and 7.4 update 61 through update 92 was found to be vulnerable to postMessage-based XSS because it allows a remote non-authenticated attacker to inject JavaScript into the fragment portlet URL.
AI-Powered Analysis
Technical Analysis
CVE-2025-4599 is a Cross-Site Scripting (XSS) vulnerability identified in the fragment preview functionality of Liferay Portal versions 7.4.3.61 through 7.4.3.132 and multiple versions of Liferay DXP 2024 quarterly releases. The vulnerability arises due to improper neutralization of input during web page generation, specifically involving the postMessage API. This flaw allows a remote attacker, without requiring authentication, to inject malicious JavaScript code into the fragment portlet URL. When a victim accesses the affected fragment preview, the injected script executes in the context of the user's browser, potentially leading to session hijacking, credential theft, or unauthorized actions on behalf of the user. The vulnerability is classified under CWE-79, which pertains to improper input sanitization leading to XSS. Despite the vulnerability's presence in multiple versions, the CVSS v4.0 score is low (2.0), indicating limited impact or exploitation complexity. The vector details suggest network attack vector (AV:N), low attack complexity (AC:L), but require privileges and user interaction (PR:H/UI:P), with low impact on confidentiality and integrity and no impact on availability. No known exploits are currently reported in the wild, and no patches have been linked yet. The vulnerability affects the fragment preview feature, which is used to render and preview UI components, making it a targeted attack vector for injecting malicious scripts via crafted URLs.
Potential Impact
For European organizations using Liferay Portal or Liferay DXP, this vulnerability poses a risk primarily to web application security and user trust. Exploitation could lead to theft of session cookies, enabling attackers to impersonate legitimate users, potentially accessing sensitive data or performing unauthorized actions within the portal. This is particularly concerning for organizations that use Liferay for intranet portals, customer-facing websites, or digital experience platforms that handle personal data or business-critical information. Although the CVSS score is low, the fact that the vulnerability can be exploited remotely without authentication increases the attack surface. European organizations subject to GDPR must consider the risk of data breaches resulting from such attacks, which could lead to regulatory penalties and reputational damage. The impact is somewhat mitigated by the requirement for user interaction and privileges, but phishing or social engineering could facilitate exploitation. Additionally, the fragment preview functionality is often used by developers and content managers, so targeted attacks against these roles could disrupt business operations or lead to privilege escalation within the portal environment.
Mitigation Recommendations
European organizations should implement the following specific mitigations: 1) Immediately audit and restrict access to the fragment preview functionality to trusted users only, minimizing exposure to untrusted or anonymous users. 2) Apply strict Content Security Policy (CSP) headers to limit the execution of unauthorized scripts within the portal context. 3) Monitor and filter incoming URLs to the fragment portlet for suspicious or malformed parameters that could carry injected scripts. 4) Educate users, especially content managers and developers, about the risks of clicking on untrusted links related to the portal. 5) Regularly update Liferay Portal and DXP to the latest versions once patches addressing CVE-2025-4599 are released. 6) Employ web application firewalls (WAFs) with custom rules to detect and block exploitation attempts targeting the fragment preview URLs. 7) Conduct internal penetration testing focusing on the fragment preview feature to identify any additional weaknesses. These measures go beyond generic advice by focusing on access control, input validation, user awareness, and proactive monitoring tailored to this specific vulnerability.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- Liferay
- Date Reserved
- 2025-05-12T17:02:55.131Z
- Cvss Version
- 4.0
- State
- PUBLISHED
Threat ID: 689126f9ad5a09ad00e339fc
Added to database: 8/4/2025, 9:32:41 PM
Last enriched: 8/12/2025, 1:00:09 AM
Last updated: 9/16/2025, 5:09:51 AM
Views: 47
Related Threats
CVE-2025-59453: CWE-669 Incorrect Resource Transfer Between Spheres in clickstudios Passwordstate
LowCVE-2025-59437: CWE-918 Server-Side Request Forgery (SSRF) in fedorindutny ip
LowCVE-2025-59436: CWE-918 Server-Side Request Forgery (SSRF) in fedorindutny ip
LowCVE-2025-10429: SQL Injection in SourceCodester Pet Grooming Management Software
MediumCVE-2025-10440: OS Command Injection in D-Link DI-8100
MediumActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.